| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.085 | 0.02 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.12 | 0.02 |
| mRNA | CHEMBL1222381 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.079 | 0.02 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | 0.085 | 0.03 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.078 | 0.03 |
| mRNA | BRD-K99584050 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.03 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.068 | 0.03 |